We demonstrated that targeting the expression of VLDLR in breast cancer cells dramatically decreased the sphere formation capacity in vitro and tumor growth in vivo (Figures 2B–E), suggesting that VLDLR plays a critical role in the BCSC phenotype. Here, VLDLR is linked to breast carcinoma.